# Pass 2 Cross-Critiques -- Research Analyst (Data Quality Focus)
**Date:** 2026-03-09
**Reviewing Analyst:** Research Analyst
**Subject:** Advanced Micro Devices, Inc. (AMD)

---

## Critique of DCF Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "WACC: 16.0% (beta 2.02, ERP 5.50% [ESTIMATED], Rf 4.15%)"

**Why it's weak:** The DCF Analyst acknowledges this is "THE most impactful variable" yet the equity risk premium of 5.50% is tagged [ESTIMATED] with no primary source. Damodaran's January 2026 implied ERP was not retrieved -- the Data Intelligence Memo flagged this as a data gap. A 5.50% ERP is within the historical range (4.5-6.5% depending on methodology and period) but the choice drives the entire model. At 4.75% ERP (Damodaran's typical implied ERP in normal markets), WACC drops to approximately 14.8%, and at 6.0% ERP (stress period), WACC rises to approximately 16.8%. The DCF Analyst correctly notes that at WACC ~13%, the base case jumps to ~$200+, meaning the ERP assumption alone can swing the conclusion from "overvalued" to "fairly valued." For a variable this consequential, [ESTIMATED] is not acceptable -- the analyst should have retrieved Damodaran's latest published ERP via WebSearch.

**Quantified impact if wrong:** At 4.75% ERP (WACC ~14.8%), the base case fair value rises from $154.58 to approximately $175-185, reducing downside from -19.1% to approximately -3% to -8%. At 6.0% ERP (WACC ~16.8%), the base case drops to approximately $140, increasing downside to ~27%. The total swing from ERP uncertainty alone is approximately $40-45/share.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** Terminal value represents 72-80% of enterprise value across all scenarios, yet the 60/40 blend of exit multiple TV ($603B) and perpetuity growth TV ($242B) has no sourced justification for the weighting.

**Why this is the most likely error:** The brief states the 60/40 blend is "highly sensitive to the weighting choice" and that a 50/50 blend reduces fair value by ~$10-15/share. But the choice of 60% exit multiple vs. 40% perpetuity is not justified by any academic source, industry precedent, or logical framework. For a company like AMD that is in the middle of a business model transformation (from CPU to AI GPU), the choice of terminal value methodology is unusually important because: (a) exit multiples assume the market will correctly value AMD in 2030, and (b) perpetuity growth assumes AMD's growth rate will converge to a steady state. These are fundamentally different assumptions about AMD's business trajectory. A semiconductor company with 60%+ of value in terminal value should at minimum sensitivity-test three blend ratios (40/60, 50/50, 60/40) and present the range.

**Suggested correction:** Present a sensitivity table showing fair value at 40/60, 50/50, and 60/40 TV blends. This adds approximately 3 rows to the sensitivity analysis and eliminates a $15-30/share source of arbitrary error.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** The mega-deal realization rate assumption of 75% (base case) needs a sourced benchmark.

**Why:** The brief cites "historical large semi deals realize 60-80%" as the basis for the 75% base case assumption, but does not name a single specific deal or source for this range. What "large semi deals" realized 60-80%? The AMD-Meta and AMD-OpenAI deals are structurally unlike prior semiconductor supply agreements because they include equity warrants (320M shares at $0.01), deployment milestones, and multi-generational product commitments. There is no historical precedent for deals of this structure and scale in the semiconductor industry. The closest analogy might be cloud infrastructure commitments (AWS/Azure capacity reservations), which have typical realization rates of 70-90%, or defense procurement contracts, which realize 60-80%. The analyst should cite the specific historical analogy being used.

**Impact on conclusion:** If mega-deal realization is 60% instead of 75%, Data Center revenue by FY2030 declines by approximately $12-15B, reducing the base case by approximately $15-20/share. If realization is 90% (approaching the bull case 95%), the base case rises by approximately $10-15/share. The range of outcomes driven by this single unsourced assumption is approximately $30-35/share.

**Severity: Medium**

---

### 4. What's Strong

The explicit modeling of warrant dilution across scenarios (0M/200M/320M shares) is rigorous and transparent. The identification that warrants create a "tax on success" -- compressing the bull case from $268 to $223 (-$45/share) -- is a critical insight that should be prominently featured in the final synthesis.

---

## Critique of Quant Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "5Y EPS CAGR: 55.9% vs. comp median ~22% [ESTIMATED]"

**Why it's weak:** The 55.9% EPS CAGR is the single most powerful input to the PEG ratio of 0.51x, which the Quant Analyst identifies as AMD's "strongest signal." But this figure is tagged [ESTIMATED] with no breakdown of how it was derived. A 55.9% EPS CAGR from FY2025 non-GAAP EPS of $4.17 implies FY2030 EPS of approximately $37 -- which would require AMD's net income to grow from ~$6.8B to ~$60B in five years, a 9x increase. For context, NVIDIA's net income grew approximately 10x from FY2020 to FY2025, but NVIDIA had a structural monopoly (CUDA) and first-mover advantage in AI that AMD does not possess. The comp median of ~22% is also [ESTIMATED]. If AMD's actual 5Y EPS CAGR is 35% (still exceptionally strong), the PEG ratio doubles from 0.51x to ~1.0x, and AMD shifts from "significantly undervalued on PEG" to "fairly valued on PEG."

**Quantified impact if wrong:** At a PEG of 1.0x instead of 0.51x, the PEG-derived fair value signal is neutralized entirely, removing the strongest quantitative argument for AMD's undervaluation. The comps-implied expected value likely drops from $205 toward $175-185.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "Exact competitor financial data retrieved from aggregators, not filings."

**Why this is the most likely error:** The comp table uses multiples from StockAnalysis.com (Tier 4) for all six comparables. For AMD, where the forward P/E of 28.6x is close to the comp median of 27.8x, a 1-2x turn difference in the median (driven by inaccurate competitor data) could flip the conclusion from "fairly valued" to "slightly overvalued." Financial aggregators frequently disagree on forward multiples because they use different consensus sources and fiscal year definitions. NVIDIA's forward P/E, for example, varies from 25x to 35x across free aggregator sites depending on whether they use CY2026 or FY2027 (ending January 2027) estimates. The Quant Analyst should have cross-checked at least NVDA and INTC multiples against a second source.

**Suggested correction:** For NVDA and INTC (the two most important comps), verify forward P/E and EV/EBITDA against at least one additional Tier 3+ source. If the comp median shifts by more than 1x turn on forward P/E, flag the discrepancy.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Address the quality score disconnect more prominently -- AMD's quality score of 29.0/100 is the worst in the comp group excluding Intel, yet the Quant Analyst's bottom line focuses on PEG-based undervaluation.

**Why:** A stock with the worst quality score in its comp group that appears cheap on PEG may be cheap for a reason -- the market is applying a quality discount. ROIC of 6.6% is below any reasonable WACC estimate (the DCF Analyst uses 16.0%). A company destroying value on ROIC should not be valued on the same PEG multiple as peers creating value. The Quant Analyst identifies this but does not resolve it -- the brief simultaneously says AMD is "significantly undervalued on PEG" and has the "weakest" quality metrics. The final conclusion should explicitly state whether the growth premium is justified despite below-WACC returns.

**Impact on conclusion:** If a quality discount of 15-20% is applied to the PEG-implied fair value, the comps estimate drops from $205 to approximately $165-175, which is materially below current price and aligns more closely with the DCF Analyst's $154 base case.

**Severity: Medium**

---

### 4. What's Strong

The identification of AMD's historical forward P/E compression from ~40x to 28.6x and the question of whether this is structural or cyclical is the most important qualitative insight in the comps analysis. If structural, it invalidates historical-multiple-based bull cases.

---

## Critique of Competitive Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "AI GPU share: ~8-12%, gained 2.6pp in Q4 2025; NVIDIA >80%" -- sourced from TechNetBooks (Tier 6).

**Why it's weak:** The market share estimate is sourced from a Tier 6 publication (TechNetBooks) with no cross-reference against a higher-tier source. GPU market share data is notoriously unreliable because neither AMD nor NVIDIA disclose unit-level AI GPU shipments. The "8-12%" range is itself wide enough (50% uncertainty band) to be nearly useless for precise competitive positioning. The Data Intelligence Memo's Tier 3 sources (Tom's Hardware, SemiAnalysis) cite similar ranges but also without primary data. No analyst should be building a competitive thesis on a 4-percentage-point uncertainty band from a Tier 6 source. Furthermore, the "2.6pp gain in Q4 2025" implies quarterly share tracking that does not exist in any published dataset I retrieved.

**Quantified impact if wrong:** If AMD's actual AI GPU share is 8% (bottom of range) vs. 12% (top), the implied AI GPU revenue at a $200B TAM differs by $8B -- a material gap when the entire Data Center segment was $5.4B in Q4.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** The CUDA Gap Score of "28.7-99.1 across benchmarks" is sourced from AIM Multiple (Tier 6) and may not reflect current ROCm performance.

**Why this is the most likely error:** The CUDA gap data source (AIM Multiple) is Tier 6 with unknown testing methodology, sample size, and benchmark date. ROCm is evolving rapidly -- AMD has made significant investments in ROCm 6.x and the Triton/MLIR abstraction layer. A gap score measured in 2024 or early 2025 may not reflect the current state. The Competitive Analyst acknowledges the CUDA moat but does not date-stamp the benchmark data or note that the gap could be narrowing. The Sentiment Analyst's brief notes AMD management's increasing confidence on the software stack, which contradicts a static gap assumption.

**Suggested correction:** Date-stamp all CUDA/ROCm benchmark comparisons and note whether they are pre- or post-ROCm 6.x release. Flag the Tier 6 sourcing explicitly and present the CUDA gap as a range that could be narrowing rather than a fixed metric.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Quantify the custom ASIC threat more precisely by cross-referencing specific hyperscaler programs.

**Why:** The brief states custom ASICs are growing at 44.6% vs. GPU at 16.1%, but the Data Intelligence Memo found that OpenAI's Broadcom custom ASIC deal is 10 GW -- 67% larger than OpenAI's AMD deal (6 GW). This specific data point, from the Devil's Advocate brief, directly challenges the Competitive Analyst's framing that "AMD's OpenAI and Meta deals suggest GPUs remain core infrastructure." If OpenAI is committing 10 GW to custom ASICs and only 6 GW to AMD GPUs, the competitive picture is more nuanced than "GPUs remain core."

**Impact on conclusion:** Could lower the overall competitive score from 6/10 to 5/10 and reduce the AI GPU moat durability assessment, which would cascade into lower DCF growth assumptions and a lower price target.

**Severity: Medium**

---

### 4. What's Strong

The server CPU competitive analysis is the best-sourced section -- AMD's EPYC share gains from 2% (2017) to 36-40% (2025) are well-documented across multiple sources, and the "one generation ahead of Intel" assessment is supported by specific performance benchmarks.

---

## Critique of Macro Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "AI capex-to-revenue ratio: 25-28:1 ($660B+ capex vs. ~$25B AI revenue) -- 6-7x more speculative than telecom bubble"

**Why it's weak:** The $660B+ capex numerator and ~$25B AI revenue denominator are both [ESTIMATED] with sourcing from Goldman Sachs and Futurum Group (Tier 3-6). The $660B figure likely aggregates all hyperscaler CapEx (including non-AI infrastructure), while the $25B denominator may count only direct AI product revenue (excluding AI-enhanced products and services). This creates an apples-to-oranges ratio. If AI-influenced revenue (including AI-driven cloud workload growth, AI features in SaaS products, and AI-optimized advertising) is $100-150B rather than $25B, the ratio drops to 4.4-6.6:1 -- within the range of the telecom bubble, not 6-7x worse. The Macro Analyst does not discuss this definitional ambiguity.

**Quantified impact if wrong:** If the capex-to-revenue ratio is 5:1 rather than 25:1, the AI capex bubble thesis weakens substantially, the catastrophic scenario probability should be reduced from 10% to 3-5%, and the macro-adjusted fair value rises from ~$190 to ~$210-220.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** "China revenue lost: ~$5.8B annualized vs. FY2024; now ~$400M/year" -- the $5.8B figure needs reconciliation.

**Why this is the most likely error:** The Data Intelligence Memo states China was "~24% of FY2024 revenue" and total FY2024 revenue was approximately $22.7B (based on Q4 FY2024 earnings context), implying ~$5.4B in China revenue. The Macro Analyst cites "$5.8B annualized" which is a different and higher figure with no source citation. The difference ($400M) matters because it affects the magnitude of the export control impact assessment. Furthermore, the "now ~$400M/year" figure appears to be calculated from Q1 2026 guidance of ~$100M/quarter, but Q4 FY2025 included $390M in one-time MI308 revenue. The annualized run-rate is genuinely uncertain -- it could be $400M (if licenses continue) or close to $0 (if further restrictions are imposed).

**Suggested correction:** Use the Tier 1 figure: China was 24% of FY2024 revenue (~$5.4B from the 10-K), now guided at $100M/quarter in Q1 2026 excluding one-time items. Present the ongoing China revenue as a range ($0-$400M annually) rather than a point estimate.

**Severity: Low**

---

### 3. Recommended Change

**What I'd change:** Source the DeepSeek efficiency impact estimate from primary data rather than general market commentary.

**Why:** The brief states "DeepSeek efficiency gains reduce inference GPU demand 15-30% over 18-36 months [ESTIMATED] [confidence: low]." This is one of the most important variables for AMD's AI GPU demand trajectory, yet it is tagged [ESTIMATED] with low confidence and no source. DeepSeek's actual efficiency improvements have been documented in their technical papers -- the R1 model achieved comparable performance to GPT-4 at approximately 1/20th the training cost. But inference efficiency improvements are different from training efficiency improvements, and the 15-30% demand reduction figure appears to be a guess. The Data Intelligence Memo's competitive intelligence section notes MI355X is "40% more tokens per dollar" than NVIDIA B200, which implies AMD may actually benefit from efficiency-driven demand (customers preferring cost-effective inference GPUs).

**Impact on conclusion:** If DeepSeek-style efficiency actually increases GPU demand (by making inference economically viable for more use cases), the macro thesis shifts from negative to neutral, and AMD's inference-optimized GPUs could see higher demand, not lower.

**Severity: Medium**

---

### 4. What's Strong

The Hormuz crisis macro overlay is well-sourced (CNBC, Kpler, Goldman Sachs -- Tier 3) and is the only macro risk that is both quantified and time-bounded. The transmission mechanism to AMD (oil -> rates -> rate cuts delayed -> P/E compression) is clearly articulated and actionable.

---

## Critique of Risk Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Annualized volatility: ~55% [ESTIMATED]; Beta: 2.02"

**Why it's weak:** The annualized volatility of 55% is [ESTIMATED] and is the primary input to every risk metric in the report (VaR, max drawdown, Sharpe ratio, position sizing). The Data Intelligence Memo flagged that historical price data was not retrieved due to a tool error, meaning the Risk Analyst had no actual price series from which to calculate volatility. The beta of 2.02 is sourced (StockAnalysis.com, Tier 4) and implies annualized volatility of approximately 2.02 x SPX vol. If SPX realized vol is 15-18%, implied AMD vol is 30-36% -- significantly lower than the 55% estimate. If SPX vol is 25% (elevated), implied AMD vol is approximately 50%. The 55% figure assumes either very high market vol or that AMD has significant idiosyncratic volatility beyond beta -- plausible but not demonstrated.

**Quantified impact if wrong:** If actual annualized vol is 35% (beta-implied at normal market vol), the Quarter Kelly recommendation changes from 9.9% to approximately 15-16%, and the vol-adjusted weight changes from 2.2% to approximately 3.5%. The Sharpe ratio improves from 0.19 to approximately 0.29. These are materially different position sizing recommendations.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "Correlation to SPX rises to 0.85+ in selloffs (asymmetric beta -- realized beta 2.4x in 2022)" -- correlation and beta figures are estimated without historical data.

**Why this is the most likely error:** The asymmetric beta claim (2.4x in 2022 downturns vs. 2.02 average) is a critical risk finding but is not sourced from actual return data. The Data Intelligence Memo could not retrieve historical price data due to tool errors. Without actual drawdown analysis, the "30%+ drawdown frequency: ~1.5 per year over 5 years" is an estimate of unknown reliability. AMD's 52-week range ($76.48-$267.08) implies a realized drawdown of approximately 71% peak-to-trough, which is far larger than what a 55% annualized vol with normal distribution would predict -- suggesting fat tails that the risk model may not capture.

**Suggested correction:** Retrieve AMD daily price data via WebSearch (Yahoo Finance provides downloadable CSV) and calculate actual 30/90/252-day realized vol, actual drawdown frequency and magnitude, and actual rolling beta. This converts [ESTIMATED] metrics to Tier 2 data.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Reconcile the Risk Analyst's expected value ($210, +10.3%) with the DCF Analyst's probability-weighted fair value ($154.07, -19.1%).

**Why:** These two models produce fundamentally different conclusions from the same company -- one says 10% upside, the other says 19% downside. The scenario probabilities differ (Risk: 25/50/25 with Bull $280/Base $220/Bear $120; DCF: 25/50/25 with Bull $223/Base $155/Bear $84). The primary difference is in the scenario price levels, not the probabilities. The Risk Analyst's base case of $220 is 42% higher than the DCF Analyst's $155. This $65 gap needs explanation -- is the Risk Analyst using a different valuation methodology, different growth assumptions, or different discount rate? Unreconciled, these figures produce contradictory position sizing recommendations.

**Impact on conclusion:** If the Director averages these two models, expected value is approximately $182 (-4.4%), which is much closer to the Devil's Advocate's $178 (-6.5%) than either standalone model. This would shift the overall thesis from marginal Buy toward Hold/Sell.

**Severity: High**

---

### 4. What's Strong

The breakeven bear probability analysis (41% vs. assessed 25%) is a powerful quantitative framework that directly informs position sizing. The identification that "position sizing, not stock selection, is the critical risk lever" is the most actionable insight in the risk report.

---

## Critique of Credit Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "GAAP EBITDA estimated at ~$7,768M; D&A estimated from non-GAAP reconciliation [ASSUMPTION]"

**Why it's weak:** The Credit Analyst estimates GAAP EBITDA rather than calculating it directly from the 10-K. The Data Intelligence Memo provided the Q4 FY2025 earnings press release with full income statement data. GAAP operating income for FY2025 was $4,711M (derived from $1,553M Q4 GAAP operating income + prior quarters). The D&A add-back drives the EBITDA calculation, and the analyst used the non-GAAP reconciliation rather than the cash flow statement's D&A line. These can differ due to treatment of acquisition-related amortization. A $500M error in D&A (plausible given the Xilinx intangible amortization of ~$2.8B/year) shifts EBITDA by 6.4%, which changes the Debt/EBITDA ratio and interest coverage metrics.

**Quantified impact if wrong:** If GAAP EBITDA is $7,268M instead of $7,768M, Debt/EBITDA rises from 0.42x to 0.45x, and interest coverage drops from 59.3x to 55.5x. These are immaterial changes given the fortress balance sheet -- the credit conclusion does not change.

**Severity: Low**

---

### 2. Most Likely Source of Error

**Error source identified:** The $12.2B purchase commitments ($8.5B in FY2026) are described as "primarily TSMC wafer purchases" without sourcing the split between take-or-pay and flexible commitments.

**Why this is the most likely error:** Purchase commitments disclosed in the 10-K typically distinguish between unconditional purchase obligations and flexible supply agreements. The credit report treats the entire $8.5B as take-or-pay risk, but a significant portion may be flexible (volume-dependent) commitments that can be adjusted with notice. The Data Intelligence Memo flagged that the full 10-K text was not reviewed (EDGAR CIK resolution failed), meaning the analyst likely did not read the commitment footnote directly. If only 50% of the $8.5B is truly take-or-pay, the downside liquidity risk is $4.25B, not $8.5B.

**Suggested correction:** Retrieve the full 10-K from the URL provided in the Data Intelligence Memo (https://ir.amd.com/financial-information/sec-filings/content/0000002488-26-000018/amd-20251227.htm) and read the purchase commitment footnote to distinguish unconditional from flexible commitments.

**Severity: Low**

---

### 3. Recommended Change

**What I'd change:** Add a warrant dilution impact assessment to the credit analysis.

**Why:** The Credit Analyst correctly notes that "320M warrant shares are equity dilution risk, not credit risk -- no cash obligations." However, warrant dilution affects credit indirectly: if 320M shares vest (increasing shares outstanding by ~20%), the share price impact reduces market cap, which affects AMD's ability to use equity as acquisition currency and its implied credit support. More importantly, the warrant vesting is tied to deployment milestones -- if deployment succeeds, AMD gets both revenue and dilution, which is net positive for credit. If deployment fails, warrants don't vest but revenue falls, which is net negative for credit. The credit analysis should model the revenue-dilution correlation rather than dismissing warrants as irrelevant.

**Impact on conclusion:** Would not change the credit rating or investment-grade assessment but would improve the stress scenario analysis and make the credit report more useful for the Director's synthesis.

**Severity: Low**

---

### 4. What's Strong

The fortress balance sheet characterization ($7.25B net cash, 0.42x leverage, 50x+ interest coverage, A/A1 ratings) is clear, well-sourced from Tier 1 data, and correctly identifies that credit is unambiguously a non-issue for AMD. This analyst appropriately kept the analysis proportionate to the risk.

---

## Critique of Catalyst Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "MI450 ramp EV: +5.9% (30% on-time strong/+25%, 45% on-time limited/+7.5%, 25% delay/-20%)"

**Why it's weak:** The probability distribution for MI450 timing (75% on-time, 25% delay) conflicts with information in the brief itself: "SemiAnalysis reports mass production Q2 2027" while AMD calls delay reports "BS." The Catalyst Analyst assigns only 25% delay probability, but the SemiAnalysis report is from a credible industry source (Tier 3) and suggests the base case may already be delayed by 2-3 quarters. If SemiAnalysis is correct and mass production is Q2 2027 (not Q3 2026), the probability distribution should be approximately 40% on-time / 60% delay, which flips the MI450 expected value from +5.9% to approximately -5% to -8%.

**Quantified impact if wrong:** If MI450 is delayed to Q2 2027, the H2 2026 catalyst stack collapses entirely -- MI450 ramp (+5.9%), OpenAI/Meta deployment (+1.8%), and NVIDIA competitive response are all negatively affected. The time-weighted 12-month expected return drops from +25-40% to approximately +5-10%, fundamentally changing the entry timing recommendation.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "Put/call ratio ~1.0" and "implied move +/-8-10%" -- all options-derived data is [ESTIMATED] because the options chain was not retrieved.

**Why this is the most likely error:** The Data Intelligence Memo flagged that options chain data could not be retrieved (market-data.sh bash version error). The Catalyst Analyst estimated the put/call ratio, implied move, and IV data from secondary sources (Barchart, Fintel -- Tier 4) rather than actual options chain data. For a catalyst-driven thesis, the options market's pricing of specific events is critical -- if the actual implied move for the Q1 earnings event is +/-12% (not 8-10%), the catalyst is priced differently than the analyst assumes. The "beat and fade" pattern from Q4 (stock rose 1.8% on a 23% EPS beat) suggests the options market may be overpricing positive catalysts, which would make call-based trade structures less attractive.

**Suggested correction:** Retrieve current ATM straddle prices via WebSearch (CBOE, Yahoo Finance options page) to get actual implied move data for the Q1 earnings date. This is Tier 2 data that is freely available.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Add the NVIDIA Vera Rubin launch timeline as an explicit catalyst with its own probability tree, rather than listing it only as a risk factor.

**Why:** The brief mentions "NVIDIA Vera Rubin competitive response limits AMD's window (85% probability)" but does not model Vera Rubin as a standalone catalyst with magnitude and timing. If NVIDIA ships Vera Rubin in H1 2026 (ahead of MI450), it could be a negative catalyst of -10-15% for AMD. If Vera Rubin is delayed to H2 2026 or later, it extends AMD's competitive window with MI350 and is a positive catalyst of +5-10%. The NVIDIA product launch is arguably as important as MI450 for AMD's stock price, and it should have its own probability tree in the catalyst calendar.

**Impact on conclusion:** Would add a negative-skew catalyst to the calendar that partially offsets the positive MI450 catalyst, potentially reducing the time-weighted 12-month expected return from +25-40% to +15-30%.

**Severity: Medium**

---

### 4. What's Strong

The "beat and fade" pattern identification from Q4 earnings (stock up only 1.8% on a 23% EPS beat) is a critical observation that most analysts would miss. This pattern suggests the market is skeptical of earnings beats as sustainable, and the analyst correctly interprets it as evidence that AMD needs catalyst confirmation (MI450 shipping), not just earnings delivery.

---

## Critique of ESG & Governance Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "Warrant issuance relied on 'inducement grant' exception or commercial arrangement classification under NASDAQ rules [DATA GAP: exact rule not confirmed]"

**Why it's weak:** The ESG/Governance Analyst correctly identifies the 320M warrant issuance without shareholder approval as a critical governance concern, but then admits the legal basis is unknown ([DATA GAP]). This is the most important governance finding in the report and the legal mechanism is unconfirmed. If AMD used a commercial arrangement exception (not an inducement grant), the precedent implications are different -- it means any commercial deal can include equity issuance without shareholder approval, which is a more concerning governance gap. The Data Intelligence Memo did not retrieve the DEF 14A proxy (EDGAR CIK resolution failed), which might contain disclosure on the authorization mechanism.

**Quantified impact if wrong:** If the warrant issuance mechanism allows unlimited future equity-for-demand deals without shareholder approval, the dilution risk is open-ended. The current 320M shares (20% dilution) could grow to 500M+ shares if AMD signs similar deals with other hyperscalers (Microsoft, Google, Amazon). This would change the governance score from 7/10 to 5-6/10 and increase the ESG WACC adjustment from +10-15bps to +25-40bps.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** Board composition data sourced from "AMD DEF 14A -- Tier 1" but the Data Intelligence Memo flagged that the DEF 14A was NOT retrieved.

**Why this is the most likely error:** The brief cites "Board: 8 members, 87.5% independent, 37.5% female, 50% racially diverse [Source: AMD DEF 14A -- Tier 1]." However, my Data Intelligence Memo explicitly states: "DEF 14A proxy statement: URL not retrieved (EDGAR CIK issue) [DATA GAP]." If the DEF 14A was not retrieved by the Research Analyst, the ESG analyst either (a) retrieved it independently via a different method (possible and acceptable), or (b) sourced the data from a secondary source and attributed it to the DEF 14A (data integrity issue). The analyst should clarify which occurred.

**Suggested correction:** If the data was retrieved independently, cite the retrieval URL and date. If sourced from a secondary aggregator, tag it as Tier 3-4 rather than Tier 1. Board composition can change -- the most recent DEF 14A may reflect a different composition than what aggregator sites show.

**Severity: Low**

---

### 3. Recommended Change

**What I'd change:** Quantify the key-person risk for Lisa Su more rigorously.

**Why:** The brief states "Lisa Su departure could cause 10-20% drawdown" without sourcing this estimate. Lisa Su has led AMD's transformation from a ~$2B market cap company to ~$310B. The Data Intelligence Memo notes she has grown revenue from $5B to ~$35B since 2014 and holds ~$600M in AMD shares. A 10-20% drawdown estimate ($31-62B market cap loss) seems low for the departure of a CEO with this track record. Historical precedents for transformational CEO departures (e.g., Steve Jobs at Apple: ~5% initial drop but sustained uncertainty; Jamie Dimon at JPMorgan: estimated 5-10%) suggest the range varies widely. The ESG analyst should cite specific comparable CEO departure events and their market impact.

**Impact on conclusion:** If the true key-person risk is 25-30% drawdown (more consistent with AMD's 2.02 beta and the magnitude of Su's personal contribution), the risk-adjusted valuation should incorporate a key-person discount of approximately $5-10/share.

**Severity: Low**

---

### 4. What's Strong

The probability-weighted expected dilution calculation (0.30 x 0% + 0.45 x 9.8% + 0.25 x 19.6% = 9.3%) is the single most useful quantitative output from the ESG report and should be directly used by the DCF and Quant Analysts in their dilution adjustments.

---

## Critique of Technical Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "All analysis from WebSearch" -- the entire technical analysis was performed without actual historical price data.

**Why it's weak:** The Data Intelligence Memo flagged that historical price data was not retrieved (market-data.sh bash version error) and rated this as "High" priority for the Technical Analyst. The Technical Analyst acknowledged this data gap but proceeded with WebSearch-derived data from Barchart and Investing.com (Tier 4). Technical analysis without actual price data is fundamentally compromised -- all moving averages, RSI, MACD, volume analysis, and support/resistance levels are approximate rather than precise. The RSI is cited as "~32-39" -- a 7-point range that spans from "oversold" (below 30) to "neutral" (above 35), making the signal ambiguous.

**Quantified impact if wrong:** If the actual RSI is 28 (below the estimated range), AMD is in genuinely oversold territory and a near-term bounce is technically likely. If the RSI is 42 (above the range), the stock has no oversold support and could continue declining. The entry timing recommendation changes significantly based on which end of the range is correct.

**Severity: Medium**

---

### 2. Most Likely Source of Error

**Error source identified:** "Death cross (50-day below 200-day) is a realistic risk within 4-8 weeks" -- this timing estimate is imprecise without actual moving average data.

**Why this is the most likely error:** The 50-day MA is cited as $241.84 and the 200-day MA as $228.48. For a death cross to occur, the 50-day must decline below the 200-day. With AMD trading at ~$192, new data points entering the 50-day calculation are well below the current 50-day average, so the 50-day will continue declining. But the rate of decline depends on the exact prices being dropped from the 50-day window (prices from 50 trading days ago) -- without actual historical price data, the timing estimate of "4-8 weeks" is a guess. If the prices being dropped are from the $160-$180 range (around the 52-week low in April 2025), the 50-day drops faster; if they're from the $230-$250 range, it drops slower.

**Suggested correction:** Retrieve the last 60 days of daily closing prices via WebSearch to calculate the exact 50-day MA trajectory and provide a precise death cross timing estimate.

**Severity: Low**

---

### 3. Recommended Change

**What I'd change:** Add a relative strength analysis vs. NVDA, not just vs. SPX and QQQ.

**Why:** For a semiconductor stock whose primary investment thesis is "gaining share from NVIDIA in AI GPUs," the most relevant relative strength comparison is AMD/NVDA, not AMD/SPX. If AMD is underperforming NVDA on a relative basis, it suggests the market is skeptical of the share-gain thesis specifically, not just semiconductors broadly. If AMD is outperforming NVDA, it validates the share-gain narrative. This is a simple ratio chart that the Technical Analyst should produce. The Data Intelligence Memo noted that NVDA comparative price data was not retrieved -- this is a gap the Technical Analyst should fill.

**Impact on conclusion:** Would provide a critical data point for the entry timing recommendation. If AMD/NVDA relative strength is at multi-year lows, it could indicate a mean-reversion entry opportunity; if it's at multi-year highs, it suggests the share-gain thesis is already priced in.

**Severity: Medium**

---

### 4. What's Strong

The identification of the $165-$185 zone as the preferred technical entry, combined with the Fibonacci retracement analysis ($194.26 at 38.2%, $149.30 at 61.8%), provides clear, actionable price levels that the Trade Structurer can use for limit order placement.

---

## Critique of Sector Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "AI GPU TAM: $140B (2025) -> $378B (2030 base, 22% CAGR)" and "Custom ASIC TAM: $28B -> $151B (40% CAGR)" -- all TAM figures are [ESTIMATED] from third parties.

**Why it's weak:** The Sector Analyst correctly acknowledges that "TAM estimates have historical tendency to overstate by 20-40% in growth sectors" but then uses the unadjusted figures as the base case. At a 30% overstatement discount (midpoint), the 2030 AI GPU TAM drops from $378B to $265B, and AMD's addressable revenue opportunity contracts proportionally. The TAM sources are Tier 5 (WSTS for overall semi) and Tier 6 (Precedence Research, industry reports) for AI GPU -- the most important growth segment has the weakest data sourcing. Furthermore, the AI GPU TAM and Custom ASIC TAM are presented separately, but there is significant overlap -- hyperscaler internal ASIC spending displaces external GPU purchases, so the combined TAM overstates total AI accelerator demand.

**Quantified impact if wrong:** If AI GPU TAM is $265B (30% discount) and AMD achieves 18.8% share (base case), AMD's implied AI GPU revenue is $49.8B instead of $71B -- a $21.2B difference that at 25x revenue multiple translates to approximately $530B in enterprise value, or ~$32/share.

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "TSMC CoWoS: ~80,000 wafers/month, >100% utilization; NVIDIA ~60% allocation, AMD ~8-10% [Source: TrendForce, Digitimes -- Tier 3]"

**Why this is the most likely error:** The TSMC capacity allocation percentages are sourced from Tier 3 industry publications (TrendForce, Digitimes) that rely on supply chain checks, not official TSMC disclosures. TSMC does not publicly disclose customer allocation splits. The "~60% NVIDIA, ~8-10% AMD" figures are widely cited but unverifiable. More importantly, these allocations are dynamic -- TSMC is expanding CoWoS capacity to 130,000 wafers/month by late 2026 (per the same Tier 3 source), and the allocation split at the expanded capacity level is entirely unknown. AMD's 12 GW mega-deal commitments may have come with TSMC capacity guarantees that are not publicly known.

**Suggested correction:** Present the TSMC allocation as a range of scenarios: (a) AMD allocation stays at 8-10% of expanded capacity = ~10,400-13,000 wafers/month, (b) AMD allocation rises to 15-20% due to mega-deal capacity agreements = ~19,500-26,000 wafers/month. Model both scenarios' impact on AMD's ability to fulfill mega-deal commitments.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Cross-reference AMD's ROIC of ~15% [ESTIMATED] against a calculated figure from the financial data.

**Why:** The Sector Analyst estimates ROIC at ~15% with the caveat of "Xilinx goodwill drag." The Quant Analyst calculates ROIC at 6.6%. This 8.4-percentage-point discrepancy is enormous and likely stems from different definitions: the Quant Analyst uses GAAP figures (depressed by Xilinx amortization), while the Sector Analyst may use non-GAAP or adjusted figures. Both are valid perspectives, but the discrepancy must be reconciled -- the difference between a 6.6% ROIC (below WACC, value-destroying) and a 15% ROIC (above a reasonable WACC, value-creating) completely changes the investment thesis.

**Impact on conclusion:** If ROIC is 6.6% (Quant Analyst), AMD is currently destroying shareholder value on a GAAP basis, which undermines the growth premium and argues for a lower multiple. If ROIC is 15% (Sector Analyst), AMD is creating value, which supports a growth premium.

**Severity: Medium**

---

### 4. What's Strong

The TSMC CoWoS capacity constraint analysis is the most differentiated finding in the sector report and adds a supply-side dimension that no other analyst addresses. The insight that AMD is "supply-constrained, not demand-constrained" reframes the investment thesis and deserves prominent placement in the final note.

---

## Critique of Devil's Advocate's Work Product

### 1. Weakest Assumption

**Assumption identified:** "DA-adjusted EV: $178.00 (-6.5%); Bull $300/20%, Base $200/45%, Bear $80/35%"

**Why it's weak:** The Devil's Advocate shifts the bear probability from 25% (consensus) to 35% and the bull from 25% to 20%. The 10-percentage-point bear shift is the entire basis for flipping AMD from positive to negative expected value, but the justification is that all five critical assumptions have "LOW" confidence. However, the five assumptions are not independent -- mega-deal execution, MI450 timing, and CUDA gap narrowing are correlated. If MI450 ships on time, mega-deal execution improves and CUDA gap concerns diminish (because deployed hardware generates ROCm adoption). The Devil's Advocate treats these as independent failure risks, which overstates the compound probability of failure. A correlated failure model would produce a bear probability of approximately 25-30%, not 35%.

**Quantified impact if wrong:** At 25% bear (instead of 35%), the DA-adjusted expected value rises from $178 (-6.5%) to approximately $195 (+2.4%), flipping the conclusion from "NEGATIVE expected value" to "marginally positive." The Kelly fraction flips from -30.7% (short) to approximately +5% (small long).

**Severity: High**

---

### 2. Most Likely Source of Error

**Error source identified:** "OpenAI Broadcom custom ASIC deal: 10 GW (67% LARGER than AMD's 6 GW deal) [Source: Tom's Hardware, CNBC -- Tier 3]"

**Why this is the most likely error:** The 10 GW OpenAI-Broadcom figure is from Tier 3 sources and has not been confirmed by OpenAI, Broadcom, or SEC filings. The Data Intelligence Memo does not include this as a confirmed data point -- I found references to OpenAI working with Broadcom on custom chips, but the 10 GW commitment is from a single Tom's Hardware report that may be extrapolating from the AMD deal structure. If the actual Broadcom deal is 3-5 GW (not 10 GW), the "bridge contract" thesis weakens because AMD's 6 GW deal would be the larger commitment, not the smaller one.

**Suggested correction:** Tag the 10 GW figure as [UNCONFIRMED, Tier 3] and present a range (3-10 GW). Note that even at 3 GW, the existence of a Broadcom ASIC deal confirms OpenAI is diversifying away from GPUs, which partially supports the bridge contract thesis.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Acknowledge the "bridge contract" thesis is unfalsifiable until 2027 and model the interim trading implications.

**Why:** The brief correctly identifies that the bridge contract thesis "is unfalsifiable until H2 2026-2027 when ASIC maturity becomes measurable." But this cuts both ways -- if the thesis is unfalsifiable, it is also uninvestable. A Devil's Advocate report should identify the specific data points that would confirm or refute the thesis, with dates. For example: (a) If OpenAI's Broadcom ASIC ships in volume by Q4 2026, the bridge thesis strengthens; (b) If MI450 deployment exceeds 1 GW by Q1 2027 with contract extensions, the bridge thesis weakens. Without falsification criteria, the bear case is a narrative, not a testable hypothesis.

**Impact on conclusion:** Would improve the actionability of the bear case and give the Director specific monitoring triggers rather than a general warning.

**Severity: Low**

---

### 4. What's Strong

The composite fragility score of 4.2/5 and the identification that "AMD at $190.40 is priced for all five critical assumptions holding simultaneously" is the single most important bearish insight across all reports. Whether the probability weights are exactly right or not, the fragility analysis correctly identifies that AMD's risk/reward is asymmetric at current prices.

---

## Critique of Forensic Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "$306M Q4 inventory reserve release: boosted Q4 GM by ~300bps (57% headline vs. ~54% underlying)"

**Why it's weak:** The 300bps impact estimate assumes the $306M reserve release flows entirely through COGS and is calculated on Q4 revenue alone (~$10.3B, implying $306M/$10.3B = 2.97%). This is arithmetically correct, but the Forensic Analyst does not confirm whether the reserve release was disclosed as a separate line item in the COGS reconciliation or is embedded in a broader adjustment. The Data Intelligence Memo's earnings press release summary mentions the $800M charge taken earlier in 2025 but does not confirm the Q4 reversal amount. If the actual reversal was $200M (not $306M), the GM inflation is ~200bps (57% vs. 55%), which is less alarming. The $306M figure's source should be cited precisely -- is it from the 10-K, the earnings call transcript, or an analyst estimate?

**Quantified impact if wrong:** If the reserve release was $200M instead of $306M, underlying GM is ~55% instead of ~54%, and the Q1 2026 guided GM of 55% represents stability rather than a step-down. This changes the narrative from "margins inflated by one-time item" to "margins roughly stable at ~55%."

**Severity: Low**

---

### 2. Most Likely Source of Error

**Error source identified:** "CFO/NI ratio: 1.79x FY2025 (1.99x FY2023, 1.89x FY2024) -- consistently >1.0x [Source: StockAnalysis.com -- Tier 4]"

**Why this is the most likely error:** The CFO/NI ratio is sourced from StockAnalysis.com (Tier 4), not from the actual 10-K cash flow statement. For AMD, the difference between GAAP and non-GAAP net income is substantial ($2.65 vs. $4.17 EPS in Q4). If the Tier 4 source uses non-GAAP net income in the denominator, the CFO/NI ratio would be approximately 1.0-1.1x rather than 1.79x -- a dramatically different earnings quality signal. The Forensic Analyst should specify whether the "NI" in CFO/NI is GAAP or non-GAAP and source it from the 10-K directly.

**Suggested correction:** Calculate CFO/NI using both GAAP NI (which includes Xilinx amortization, making the ratio artificially high) and non-GAAP NI (which strips amortization, giving a more comparable ratio). Report both figures.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Add an analysis of future accounting complexity from the mega-deal warrant structures.

**Why:** The Forensic Analyst identifies this as a weakest point ("future accounting treatment of 320M warrant equity instruments and multi-year deployment contract revenue recognition will introduce complexity") but does not analyze it. Under ASC 606, the warrants issued to customers (OpenAI, Meta) at below-market exercise price ($0.01) must be measured at fair value and recognized as a reduction of revenue over the contract period. If the warrants are worth approximately $30B at current stock price ($190 x 160M = $30.4B per customer), this creates a massive revenue reduction over the contract life. The actual revenue recognition treatment will significantly affect reported revenues and margins in FY2027+. This is not a future concern -- it affects how investors should interpret forward estimates today.

**Impact on conclusion:** If $30B+ in warrant fair value is recognized as a revenue reduction over 5-7 years, reported Data Center revenue growth could be 5-10 percentage points lower than economic revenue growth. This would depress reported margins and could trigger multiple compression when the accounting treatment becomes visible in quarterly results.

**Severity: Medium**

---

### 4. What's Strong

The Beneish M-Score (-2.71) and Altman Z-Score (14.38) calculations are rigorous, well-sourced, and provide clear, calibrated signals against established thresholds. The accounting quality rating of 4/5 with transparent reasoning for the cap is a model of how forensic analysis should be presented.

---

## Critique of Sentiment Analyst's Work Product

### 1. Weakest Assumption

**Assumption identified:** "CEO credibility score: 8.5/10; CFO credibility: 7/10" -- these scores have no disclosed calibration methodology.

**Why it's weak:** The credibility scores are the Sentiment Analyst's subjective assessments with no defined scoring rubric. What would an 8/10 CEO credibility look like vs. a 9/10? Is 8.5 based on historical guidance accuracy, market perception, or interview tone? The Data Intelligence Memo confirms Lisa Su has beaten consensus estimates for 6+ consecutive quarters, which is objectively strong. But the 8.5/10 score does not distinguish between "CEO who consistently beats low-balled guidance by 5-10%" (sandbagging) and "CEO who provides accurate guidance that is subsequently beaten by strong execution" (genuine outperformance). The difference matters for interpreting the new long-term targets (>60% DC CAGR, >$20 EPS) -- if Su is a sandbagger, these targets are conservative; if she is now making stretch targets, they may not be achievable.

**Quantified impact if wrong:** If CEO credibility is 6/10 (reflecting the shift from conservative to ambitious targets), the long-term growth targets should be discounted by 20-30%, which would reduce the DCF Analyst's bull case revenue by $15-25B and lower the bull case fair value by approximately $20-30/share.

**Severity: Low**

---

### 2. Most Likely Source of Error

**Error source identified:** "No Q3 FY2025 full transcript retrieved -- cross-quarter comparison based on partial data and Investing.com/AlphaStreet summaries"

**Why this is the most likely error:** The Sentiment Analyst flags this data gap transparently, but the consequence is that the cross-quarter trend analysis (tone score rising from ~76 to 82) is based on incomplete data. The Q3 transcript is the baseline for measuring whether Lisa Su's tone shifted between Q3 (pre-Meta deal) and Q4 (post-Meta deal announcement). Without the full Q3 transcript, the hedging density comparison, confidence ratio trend, and forward/backward ratio evolution are all approximate. The Data Intelligence Memo retrieved the Q4 transcript (Motley Fool, Tier 2) but the Q3 transcript was not retrieved -- the Sentiment Analyst should have requested it via the Motley Fool or company IR page.

**Suggested correction:** Retrieve the Q3 FY2025 transcript from Motley Fool (they typically cover AMD earnings calls) and recalculate the cross-quarter metrics. If the tone shift from 76 to 82 is confirmed, it adds confidence to the "management increasingly bullish" narrative. If Q3 tone was actually 80+, the shift is less pronounced.

**Severity: Medium**

---

### 3. Recommended Change

**What I'd change:** Quantify the "GPU revenue opacity" red flag with a specific estimate of what Instinct GPU revenue might be.

**Why:** The Sentiment Analyst identifies AMD's refusal to disclose Instinct GPU revenue as a "MEDIUM-HIGH severity" red flag, correctly noting that "if the AI GPU story were as strong as management tone suggests, breaking out GPU revenue would strengthen the narrative." But the report stops at identification without estimation. The Data Intelligence Memo provides Data Center segment revenue of $5.4B in Q4. Industry analysts (Morgan Stanley, Bernstein) have estimated Instinct GPU revenue at $2-3B per quarter based on channel checks. If AMD's Instinct revenue is $2B/quarter (~37% of Data Center), the implied GPU growth rate and margin profile can be inferred. If it's $3.5B+ (~65% of Data Center), the GPU business is already dominant and the opacity is likely a competitive strategy, not a weakness signal. The Sentiment Analyst should attempt this decomposition.

**Impact on conclusion:** An estimated Instinct GPU revenue figure would allow the DCF Analyst to model CPU vs. GPU growth trajectories separately, improving model precision and potentially changing the scenario probabilities.

**Severity: Medium**

---

### 4. What's Strong

The hedging density analysis (Q&A hedging density +76% vs. prepared remarks at 13.2 vs. 7.5/1000 words) is the most quantitative and diagnostic metric in the sentiment report. The insight that management becomes significantly more cautious when answering unscripted questions -- particularly about China and competitive positioning -- is directly actionable for interpreting future earnings calls.

---

*Critique by Research Analyst, Equity Research Swarm. Pass 2 adversarial review. Focus: data quality, source reliability, and analytical precision.*
